Variants in Epithelial-Mesenchymal Transition and Immune Checkpoint Genes Are Associated With Immune Cell Profiles and Predict Survival in Non-Small Cell Lung Cancer.
CONCLUSIONS.—: Genetic variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and may predict patient outcomes and response to immune checkpoint blockade.
PMID: 32150457 [PubMed - as supplied by publisher]
Source: Archives of Pathology and Laboratory Medicine - Category: Laboratory Medicine Authors: Parra ER, Jiang M, Machado-Rugolo J, Yaegashi LB, Prieto T, Farhat C, de Sá VK, Nagai MA, de Lima VCC, Takagaki T, Terra R, Fabro AT, Capelozzi VL Tags: Arch Pathol Lab Med Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Carcinoma | Epithelial Cancer | Genetics | Immunotherapy | Laboratory Medicine | Lung Cancer | Non-Small Cell Lung Cancer | Pathology